United StatesLidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL single‑dose vial, Rx Only (NDC 55150‑164‑02), manufactured for Eugia US LLC — lots 3LC26029A (exp Feb 2029) and 3LC26031A (exp Mar 2029) — is affected. The product was recalled because the label wrap covers the barcode, making it hard to scan.
What's being recalled
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
Recalling firm: Eugia US LLC, East Windsor, NJ, United States.
How to identify it
Lot, expiry: Lot 3LC26029A, exp Feb-2029; Lot 3LC26031A, exp Mar-2029
The hazard
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)